Frailty is characterized by biomarker patterns reflecting inflammation or muscle catabolism in multi-morbid patients.
Bastian KochlikKristina FranzThorsten HenningDaniela WeberAndreas WernitzCatrin HerpichFranziska JannaschVolkan AykaçUrsula Müller-WerdanMatthias B SchulzeTilman GruneKristina NormanPublished in: Journal of cachexia, sarcopenia and muscle (2022)
We conclude that two specific patterns reflecting either inflammation-related or muscle-related biomarkers are both significantly associated with frailty among multi-morbid patients and that these specific biomarker patterns are more informative than single biomarker analyses considering frailty identification.